Join our daily newsletter At The Bell to receive exclusive market insights
- Founders of ASX 200 company Pro Medicus have offloaded large portions of their shareholdings — banking a total $72 million
- CEO Dr Sam Hupert sold one million of his shares and now holds a 27.03 per cent stake in the company at 28,107,660 remaining shares
- Executive Director Anthony Hall also sold one million of his shares, now retaining 26.99 per cent in the company at 28,067,500 remaining shares
- Dr Sam and Anthony founded Pro Medicus in 1983 to help radiologists organise their workflow and efficiency, three years into Dr Sam’s practicing career
The founders of ASX 200 company Pro Medicus have offloaded their shares for a total return of $72 million.
The news broke this morning after the large-cap company posted a media release to shareholders in the ASX.
At the time of the sell down for both board members, shares in Pro Medicus were valued at $36 apiece.
Co-founder and CEO Dr Sam Hupert sold one million of his shares in Pro Medicus. However, the medical school graduate still holds 28,107,660 shares in the company — a 27.03 per cent stake holding.
Executive Director and Co-founder Anthony Hall also sold one million of his shares. He now holds 28,067,500 in Pro Medicus, representing a 26.99 per cent stake holding.
Dr Sam and Anthony founded Pro Medicus in 1983. At the time, Dr Sam was three years into his career as a practicing doctor. He earned his credentials from Monash University, Melbourne Australia.
Anthony pioneered principal design and software architecture at the conception of Pro Medicus. Anthony earned his Master’s degree from La Trobe University, Melbourne Australia.
Both Dr Sam Hupert and Anthony Hall informed the company in letters of notice they do not intend to sell any more shares until the release of company’s half year results in February 2020.
They both also noted the possibility of not selling anymore Pro Medicus shares at all and retaining their current holdings.
At yesterday’s close in the ASX, shares in Pro Medicus were valued at $37.97 apiece. Today, at roughly midday AEST, shares in Pro Medicus are valued at $34.45 each. The company’s market cap today is $3.948 billion.
Pro Medicus is a company specialising in developing radiology-focused information systems. One of the company’s products, Visage 7, helps practitioners with surgery precision and workflow.
